The twist is that a subset of gut bacteria can chew on L-carnitine and related nutrients and make a small volatile compound called trimethylamine or TMA
The institute recommended that existing GLP-1 makers, and those with products in the pipeline, should consider steep discounts to prices in exchange for higher volume. What has to happen is we have to move from a low-volume, high-price business model, to a high-volume, low-price business model, Nunn said
Their small size and ability to interact with cellular receptors make peptides versatile in pharmacology, offering targeted therapies with fewer side effects compared to traditional drugs
Researchers caution that many of the studies remain in early stages and that significant questions remain unanswered, particularly for children and adolescents whose brains are still developing
For these reasons, limited treatment options exist for this patient population
The active ingredient, semaglutide, is currently licensed in the UK as a type 2 diabetes treatment under the brand name Ozempic and Rybelsus